¡Atención! Este sitio usa cookies y tecnologías similares.

Si no cambia la configuración de su navegador, usted acepta su uso. Saber más



Bibliografía magnesio


  • Anonymous. (2009, 27 Jul 2009). "Community Nutrition Mapping Project CNMap." Retrieved 9 Feb, 2010, from http://www.ars.usda.gov/Services/docs.htm?docid=10709.
  • Belin, R. J. and K. He (2007). "Magnesium physiology and pathogenic mechanisms that contribute to the development of the metabolic syndrome." Magnes Res 20(2): 107-129.
  • Barbagallo M, Belvedere M, Dominguez LJ (2009). Magnesium homeostasis and aging. Magnes Res 2009 Dec; 22(4):235-46.
  • Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M (2010). Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010 Aug 24.
  • Bo, S. and E. Pisu (2008). "Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes." Curr Opin Lipidol 19(1): 50-56.
  • Chiuve SE, Korngold EC, James LJ Jr, Gantzer ML, Albert C. (2011). Plasma and dietary magnesium and risk of sudden cardiac death in women. © 2011 Sociedad Americana para la Nutrición.
  • Crippa, G., E. Sverzellati, et al. (1999). "Magnesium and cardiovascular drugs: interactions and therapeutic role." Ann Ital Med Int 14(1): 40-45.
  • Dae Jung Kim, Penqcheng Xun, Kiang Liu, Catherine Loria, Kuninobu Yokota, David R. Jcobs Jr, Ka He (2010).  Magnesium Intake in Relation to Systemic Inflammation, Insulin Resistance, and the Incidence of Diabetes. Diabetes Care Published online before print August 31, 2010, doi: 10.2337/dc10-0994
  • Durlach, J., N. Pages, et al. (2003). "Beta-2 mimetics and magnesium: true or false friends?" Magnes Res 16(3): 218-233.
  • Durlach J, Pagès N, Bac P, Bara M, Guiet-Bara A. (2005). Magnesium depletion with hypo- or hyper- function of the biological clock may be involved in chronopathological forms of asthma. Magnes Res 2005 Mar; 18(1):19-34.
  • Ehrlich, S. D. (2009, 25 Jun 2009). "Magnesium." fromhttp://www.umm.edu/altmed/articles/magnesium-000313.htm.
  • Elin RJ (2010). Assessment of magnesium status for diagnosis and therapy. Magnes Res 2010 Aug 24.
  • Firoz, M. and M. Graber (2001). "Bioavailability of US commercial magnesium preparations." Magnes Res 14(4): 257-262.
  • Inoue, I. (2005). "[Lipid metabolism and magnesium]." Clin Calcium 15(11): 65-76.
  • King DE. (2009). Inflammation and elevation of C-reactive protein: does magnesium play a key role?  Magnes Res 2009 Jun; 22(2):57-9.
  • Kontani, M., A. Hara, et al. (2005). "Hypermagnesemia induced by massive cathartic ingestion in an elderly woman without pre-existing renal dysfunction." Intern Med 44(5): 448-452.
  • Kowal, A., B. Panaszek, et al. (2007). "The use of magnesium in bronchial asthma: a new approach to an old problem." Arch Immunol Ther Exp (Warsz) 55(1): 35-39.
  • Kramer, J. H., C. Spurney, et al. (2009). "Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia." Am J Med Sci 338(1): 22-27.
  • Kumeda, Y. and M. Inaba (2005). "[Metabolic syndrome and magnesium]." Clin Calcium 15(11): 97-104.
  • Laires, M. J. and C. Monteiro (2008). "Exercise, magnesium and immune function." Magnes Res 21(2): 92-96.
  • Larsson, S. C., M. J. Virtanen, et al. (2008). "Magnesium, calcium, potassium, and sodium intakes and risk of stroke in male smokers." Arch Intern Med 168(5): 459-465.
  • Lindberg, J. S., M. M. Zobitz, et al. (1990). "Magnesium bioavailability from magnesium citrate and magnesium oxide." J Am Coll Nutr 9(1): 48-55.
  • Nielsen FH, Johnson LK, Zeng H (2011). Magnesium supplementation improves indicators of low magnesium status and inflammatory stress in adults older than 51 years with poor quality sleep. Magnes Res. 2011 Jan 4.
  • Peacock JM, Ohira T, Post W, Sotoodehnia N, Rosamond W, Folsom AR. (2010). Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010 Sep;160(3):464-70
  • Rosanoff A. (2010). Magnesium supplements may enhance the effect of antihypertensive medications in stage 1 hypertensive subjects. Magnes Res 2010 Mar; 23(1):27-40.
  • Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. (2006). High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res 2006 Dec; 19(4):237-43.
  • Rodríguez-Morán M, Guerrero-Romero F. de suplementos de magnesio oral mejora la sensibilidad a la insulina y el control metabólico en sujetos diabéticos tipo 2: A randomized double-blind controlled trial. Diabetes Care. 2003;26(4):1147-1152.
  • Shechter M (2010). Magnesium and cardiovascular system. Magnes Res 2010 Mar 31.
  • Sontia, B. and R. M. Touyz (2007). "Role of magnesium in hypertension." Arch Biochem Biophys 458(1): 33-39.
  • Stepura, O. B. and A. I. Martynow (2009). "Magnesium orotate in severe congestive heart failure (MACH)." Int J Cardiol 131(2): 293-295.
  • Takaya J, Higashino H, Kobayashi Y. (2004). Intracellular magnesium and insulin resistance. Magnes Res 2004 Jun; 17(2):126-36.
  • Tong, G. M. and R. K. Rude (2005). "Magnesium deficiency in critical illness." J Intensive Care Med 20(1): 3-17.
  • Tosiello L. hipomagnesemia y diabetes mellitus. A review of clinical implications. Arch Intern Med. 1996;156(11):1143-1148.
  • Ueshima K (2005). Magnesium and ischemic heart disease: a review of epidemiological, ex perimental, and clinical evidences. Magnes Res 2005 Dec; 18(4):275-84.
  • Yokota K, Kato M, Lister F, et al. 35. Yokota K, Kato H, Lister F, et al. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr. 2004;23(5):506S-509S.
  • Walker, A. F., G. Marakis, et al. (2003). "Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study." Magnes Res 16(3): 183-191.
  • Wester, P. O. (1987). "Magnesium." Am J Clin Nutr 45(5 Suppl): 1305-1312.
  • Abraham GE, Flechas JD. Management of fibromyalgia: rationale for the use of magnesium and malic acid. J Nutr Med. 1992:3:49-59.
  • Cox, I.M, et. al. Red blood cell magnesium and chronic fatigue syndrome. The Lancet, 1991: Volume 337:8744;757–760. 
  • Porter NS, Jason LA, Boulton A, Bothne N, Coleman B.Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010 Mar;16(3):235-49. 
  • Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 2000 Apr;5(2):93-108.